hypercoagulability


Also found in: Dictionary, Medical, Wikipedia.

hypercoagulability

[‚hī·pər·kō‚ag·yə·lə′bil·əd·ē]
(medicine)
Coagulation of blood more rapidly than normal.
References in periodicals archive ?
Effect of estrogens on postpartum hypercoagulability and antithrombin III activity.
Routine evaluation for hypercoagulability such as assays for deficiencies of coagulation inhibitors, or genetic analysis for factor V Leiden or prothrombin 20210, are not helpful in identifying risk factors for adult patients with stroke.
As genetic testing becomes standard practice for the diagnosis of many "medical" diseases, such as hypercoagulability or cardiovascular disease, who will provide adequate counseling to patients and their family members?
The triad of stasis, vessel injury, and hypercoagulability formulated by Virchow remain the foundation for our understanding of the pathophysiology of DVT in general and for IVCT in particular.
1,7) The patient in this report had thrombosis of the posterior cerebral artery and subsequent occipital infarction, which was possibly caused by a combination of hypercoagulability from factor V Leiden mutation and direct vascular damage from marijuana use.
increased concentration of fibrinogen as well as increased concentrations of FVIII, which could explain a shift of the hemostatic balance to hypercoagulability and thrombophilia as a cause of an increased activity of the procoagulant system.
This decreased Prothrombin time may be because of change in haemostatic balance in the direction of Hypercoagulability in which increase concentration of all clotting factors except XI, XIII.
Asymptomatic individuals with underlying hypercoagulability may not require treatment except in clot-promoting situations such as trauma, pregnancy, recent surgery, or use of venous access devices.
8) Hypercoagulability in cirrhosis is multifactorial with increased factor VIII: C levels along with a reduction in albumin and protein C levels often tilting the balance.
15-17) In contrast, hypercoagulability can result from platelet hyperactivity or disorders of coagulation regulatory factors.
The increased risk of thromboembolic events in malignancy is well documented in literature and has many causes including chemotherapy, surgical intervention, immobilization and malignancy induced hypercoagulability.